Search results
Health Care Roundup: Market Talk
The Wall Street Journal· 44 minutes ago0710 GMT – Novartis raised its outlook after first-quarter results beat Barclays and market expectations on a stronger-than-expected business performance...
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC...
ThePress.net· 14 hours agoPharmAbcine, Inc. ("PharmAbcine" or the "Company") (KOSDAQ: 208340), a clinical-stage public company developing next generation therapeutics to treat medical unmet needs, announced today that ...
Toppling Goliath Brewing Co. partners with BREWS for BLiNDNESS
The Hannibal Courier-Post· 5 days agoToppling Goliath Brewing Co. has partnered with Iowa based Non-Profit BREWS for BLiNDNESS to support...
Byooviz dosage: Form, strength, when to use, and more
Medical News Today· 5 days agoByooviz (ranibizumab-nuna) is a brand-name drug prescribed for certain eye conditions in adults. It...
Nanoscope Therapeutics to Present at the World Orphan Drug Congress 2024
WTVO - WQRF Rockford· 6 days ago...Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for inherited retinal diseases and age-related macular degenerations (AMD), today announced that Sulagna Bhattacharya, Chief Executive Officer and Samarendra...application of Nanoscope's...
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
Morningstar· 5 days ago(NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet ...
Clearside Biomedical appoints new board member By Investing.com
Investing.com· 7 days agoClearside Biomedical, Inc. (NASDAQ:CLSD), a company focused on developing treatments for eye...
I Can See Clearly Now: Eye Care for Seniors Begins at 50 - The Baltimore Times
Baltimore Times· 4 days agoIf you can recall the Johnny Nash 70’s chart-topping hit “I Can See Clearly Now” or grew up watching...
Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2...
Morningstar· 4 days agoGA affects approximately 1 million people in the United States alone.
The 3 Best Biotech Stocks to Buy Now: Q2 Edition
InvestorPlace via Yahoo Finance· 7 days agoSome of the hottest opportunities can be found in biotech stocks to buy now. With innovation, mergers and acquisitions, major companies looking to...
